Strive Health is a value-based kidney care company, and this weekly summary highlights its recent focus on care management workflows and artificial intelligence in nephrology. The company used a series of LinkedIn posts to promote an April 30 “lunch and learn” webinar and to outline its strategy around AI-enabled partnerships with provider groups.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The upcoming webinar will center on transitional care management and care coordination, with Strive’s chief nephrologist, a regional medical director and its vice president of complex clinical operations presenting. They plan to showcase workflows that align clinical teams and care management partners to help reduce hospital readmissions and improve outcomes for shared patients.
By emphasizing best practices in transitional care, Strive is positioning itself as an enabling partner for providers managing complex, high-cost populations such as kidney care patients. The company appears to be using educational outreach to deepen engagement with existing and prospective provider partners, which could support contract retention and expansion over time.
In parallel, Strive highlighted that artificial intelligence was a central theme at the Renal Physicians Association 2026 Annual Meeting and that nephrology practices nationwide are now actively developing AI strategies. The company noted key operational hurdles, including a crowded field of point solutions, difficult EMR integration and a lack of nephrology-specific AI tools.
Strive is positioning its strategy around co-developing AI-enabled solutions with provider groups, embedding clinical input into design and deployment. This collaborative, workflow-centric approach is intended to create tools that are tightly integrated into care delivery and value-based contracts, rather than standalone point products.
If Strive’s transitional care workflows and AI initiatives gain adoption and demonstrate measurable outcome improvements, they could enhance the company’s value proposition with payers and health systems. That, in turn, may support more durable relationships, higher switching costs and more predictable revenue streams in risk-sharing arrangements.
Overall, the week underscored Strive Health’s twin focus on operational excellence in care management and differentiated AI partnerships in kidney care, signaling a continued push to strengthen its role in value-based nephrology.

